TY - JOUR
T1 - Evaluating the severity of depressive symptoms using upper body motion captured by RGB-depth sensors and machine learning in a clinical interview setting
T2 - A preliminary study
AU - Horigome, Toshiro
AU - Sumali, Brian
AU - Kitazawa, Momoko
AU - Yoshimura, Michitaka
AU - Liang, Kuo ching
AU - Tazawa, Yuki
AU - Fujita, Takanori
AU - Mimura, Masaru
AU - Kishimoto, Taishiro
N1 - Funding Information:
Dr. Kishimoto has received consultant fees from Dainippon Sumitomo, Novartis, and Otsuka, and speaker's honoraria from Banyu, Eli Lilly, Dainippon Sumitomo, Janssen, Novartis, Otsuka, and Pfizer. He has received grant support from Pfizer Health Research Foundation, Dainippon Sumitomo, Otsuka, and Mochida.We appreciate Mr. Satoshi Maemoto and Mr. Kai Zaremba for technical support. This research is supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP18he1102004.
Funding Information:
This research is supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP18he1102004 .
Publisher Copyright:
© 2020 The Authors
PY - 2020/4
Y1 - 2020/4
N2 - Background: Mood disorders have long been known to affect motor function. While methods to objectively assess such symptoms have been used in experiments, those same methods have not yet been applied in clinical practice because the methods are time-consuming, labor-intensive, or invasive. Methods: We videotaped the upper body of each subject using a Red-Green-Blue-Depth (RGB-D) sensor during a clinical interview setting. We then examined the relationship between depressive symptoms and body motion by comparing the head motion of patients with major depressive disorders (MDD) and bipolar disorders (BD) to the motion of healthy controls (HC). Furthermore, we attempted to predict the severity of depressive symptoms by using machine learning. Results: A total of 47 participants (HC, n = 16; MDD, n = 17; BD, n = 14) participated in the study, contributing to 144 data sets. It was found that patients with depression move significantly slower compared to HC in the 5th percentile and 50th percentile of motion speed. In addition, Hamilton Depression Rating Scale (HAMD)-17 scores correlated with 5th percentile, 50th percentile, and mean speed of motion. Moreover, using machine learning, the presence and/or severity of depressive symptoms based on HAMD-17 scores were distinguished by a kappa coefficient of 0.37 to 0.43. Limitations: Limitations include the small number of subjects, especially the number of severe cases and young people. Conclusions: The RGB-D sensor captured some differences in upper body motion between depressed patients and controls. If much larger samples are accumulated, machine learning may be useful in identifying objective measures for depression in the future.
AB - Background: Mood disorders have long been known to affect motor function. While methods to objectively assess such symptoms have been used in experiments, those same methods have not yet been applied in clinical practice because the methods are time-consuming, labor-intensive, or invasive. Methods: We videotaped the upper body of each subject using a Red-Green-Blue-Depth (RGB-D) sensor during a clinical interview setting. We then examined the relationship between depressive symptoms and body motion by comparing the head motion of patients with major depressive disorders (MDD) and bipolar disorders (BD) to the motion of healthy controls (HC). Furthermore, we attempted to predict the severity of depressive symptoms by using machine learning. Results: A total of 47 participants (HC, n = 16; MDD, n = 17; BD, n = 14) participated in the study, contributing to 144 data sets. It was found that patients with depression move significantly slower compared to HC in the 5th percentile and 50th percentile of motion speed. In addition, Hamilton Depression Rating Scale (HAMD)-17 scores correlated with 5th percentile, 50th percentile, and mean speed of motion. Moreover, using machine learning, the presence and/or severity of depressive symptoms based on HAMD-17 scores were distinguished by a kappa coefficient of 0.37 to 0.43. Limitations: Limitations include the small number of subjects, especially the number of severe cases and young people. Conclusions: The RGB-D sensor captured some differences in upper body motion between depressed patients and controls. If much larger samples are accumulated, machine learning may be useful in identifying objective measures for depression in the future.
KW - Depression
KW - Machine learning
KW - Psychomotor agitation
KW - Psychomotor retardation
KW - RGB-Depth sensor
KW - Upper body motion
UR - http://www.scopus.com/inward/record.url?scp=85080890100&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85080890100&partnerID=8YFLogxK
U2 - 10.1016/j.comppsych.2020.152169
DO - 10.1016/j.comppsych.2020.152169
M3 - Article
AN - SCOPUS:85080890100
SN - 0010-440X
VL - 98
JO - Comprehensive Psychiatry
JF - Comprehensive Psychiatry
M1 - 152169
ER -